Granite Bay Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Granite Bay Wealth Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,449	Closed	-$232K	–	82
2024 Q1	$232K	Buy	+2,449	New	+$227K	0.13%	72
2023 Q2	$414K	Sell	4,974 -3,978	-44%	-$333K	0.39%	33
2023 Q1	$682K	Hold	8,952	–	–	0.48%	34
2022 Q4	$743K	Sell	8,952 -850	-9%	-$68.8K	0.48%	28
2022 Q3	$777K	Buy	9,802 +202	+2%	+$17K	0.62%	23
2022 Q2	$713K	Buy	9,600 +400	+4%	+$30K	0.55%	25
2022 Q1	$827K	Buy	9,200 +6,450	+235%	+$596K	0.67%	24
2021 Q4	$308K	Buy	+2,750	New	+$332K	0.3%	39

Other funds holding XBI

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Granite Bay Wealth Management's XBI Position: Q2 2024 in Review

Granite Bay Wealth Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2024, closing a stake of 2,449 shares — an estimated $232K sold.

Granite Bay Wealth Management first reported a position in XBI in Q4 2021 and held it in 8 quarters. The position peaked at $827K in Q1 2022. 761 funds tracked by Wall St. Rank hold XBI as of Q2 2024.

Granite Bay Wealth Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2024 after selling out during the quarter.
Granite Bay Wealth Management sold 2,449 State Street SPDR S&P Biotech ETF shares in Q2 2024, an estimated $232K.
Granite Bay Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and held it in 8 quarters.
Granite Bay Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $827K in Q1 2022.
761 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2024.

Based on Granite Bay Wealth Management's 13F filing for Q2 2024, filed 15 Jul 2024.